These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2959242)

  • 21. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of CR1 mobilization of human granulocytes by the presence of erythrocytes. A possible mechanism for intravascular regulation of granulocyte modulation.
    Forslid J; Halldén G; Hed J
    Immunology; 1991 Dec; 74(4):685-8. PubMed ID: 1838355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Miyamoto T
    J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.
    Miyakawa Y; Yamada A; Kosaka K; Tsuda F; Kosugi E; Mayumi M
    Lancet; 1981 Sep; 2(8245):493-7. PubMed ID: 6115248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte C3b receptors in juvenile rheumatoid arthritis.
    Mäkelä AL; Eerola E; Lehtonen OP; Ruuska P; Lantto R
    N Engl J Med; 1983 Sep; 309(11):673. PubMed ID: 6225022
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decreased C3b receptors of erythrocytes in patients with rheumatoid arthritis--with special reference to the vasculitis syndrome].
    Yoshizawa H; Takahashi K; Okudaira K; Arata M; Tsuda F; Takai E
    Ryumachi; 1985 Jul; 25(3):151-3. PubMed ID: 2933829
    [No Abstract]   [Full Text] [Related]  

  • 28. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus.
    Cook JM; Kazatchkine MD; Bourgeois P; Mignon F; Mery JP; Kahn MF
    Clin Immunol Immunopathol; 1986 Jan; 38(1):135-8. PubMed ID: 2934195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease.
    Buffone GJ; Leatherwood CM; Person DA; Brewer EJ
    Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritis.
    Thomsen BS; Heilmann C; Jacobsen SE; Pedersen FK; Morling N; Jakobsen BK; Svejgaard A; Nielsen H
    Arthritis Rheum; 1987 Sep; 30(9):967-71. PubMed ID: 2959290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between C3b receptor (CR1) activity of erythrocytes and positive Coombs' tests.
    Inada Y; Kamiyama M; Kanemitsu T; Clark WS; Asai Y
    Ann Rheum Dis; 1986 May; 45(5):367-72. PubMed ID: 2940981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.
    Ruuska P; Ilonen J; Mustonen A; Tiilikainen A
    Clin Exp Immunol; 1984 Jul; 57(1):12-6. PubMed ID: 6235073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.